Literature DB >> 23509527

Pharmacists and harm reduction: A review of current practices and attitudes.

Tyler Watson, Christine Hughes.   

Abstract

BACKGROUND: Injection drug use and other high-risk behaviours are the cause of significant morbidity and mortality and thus have been the focus of many health promotion strategies. Community pharmacists are considered underutilized health providers and are often thought to be more accessible than other health professionals. The purpose of this review is to provide an overview of community pharmacists' practices as well as pharmacists' attitudes and identified barriers toward providing harm reduction services. We will highlight the major harm reduction services being offered through community pharmacies, as well as identify barriers to implementing these services.
METHODS: A review of the literature from 1995 to 2011 was conducted using the electronic databases MEDLINE, PubMed and Scopus, encompassing pharmacists' involvement in harm reduction services. Keywords included pharmacist, harm reduction, disease prevention, health promotion, attitudes, competence and barriers. References of included articles were examined to identify further relevant literature.
RESULTS: Pharmacists are primarily involved in providing clean needles to injection drug users, as well as opioid substitution. Pharmacists generally have a positive attitude toward providing health promotion and harm reduction programs and express some interest in increasing their role in this area. Common barriers to expanding harm reduction strategies in community pharmacists' practice include lack of time and training, insufficient remuneration, fear of attracting unruly clientele and inadequate communication between health providers.
CONCLUSION: As one of the most accessible health care providers, community pharmacists are in an ideal position to provide meaningful services to injection drug users. However, in order to do so, pharmacists require additional support in the form of better health team and system integration, as well as remuneration models.

Entities:  

Year:  2012        PMID: 23509527      PMCID: PMC3567507          DOI: 10.3821/145.3.cpj124

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


  20 in total

1.  Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia.

Authors:  Jennifer Taussig; Benjamin Junge; Scott Burris; T Stephen Jones; Claire E Sterk
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

2.  Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.

Authors:  Nickolas Zaller; Alexandra Jeronimo; Jeffrey Bratberg; Patricia Case; Josiah D Rich
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

3.  High HIV knowledge relates to low stigma in pharmacists and university health science students in Guyana, South America.

Authors:  Louise Balfour; Kimberly Corace; Giorgio A Tasca; Wallis Best-Plummer; Paul A Macpherson; D William Cameron
Journal:  Int J Infect Dis       Date:  2010-08-02       Impact factor: 3.623

4.  Role of Service Providers of Needle Syringe Program in Preventing HIV/AIDS.

Authors:  Tzu-I Tsai; Donald E Morisky; Yi-Ming A Chen
Journal:  AIDS Educ Prev       Date:  2010-12

5.  A survey of community pharmacists on prevention of HIV and hepatitis B and C: current practice and attitudes in Grampian.

Authors:  Lorna Watson; Christine Bond; Caroline Gault
Journal:  J Public Health Med       Date:  2003-03

6.  Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.

Authors:  Abby E Rudolph; Natalie D Crawford; Danielle C Ompad; Ebele O Benjamin; Rachel J Stern; Crystal M Fuller
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Mar-Apr 1

7.  Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.

Authors:  Catriona Matheson; Christine M Bond; Michela Tinelli
Journal:  J Public Health (Oxf)       Date:  2007-11-06       Impact factor: 2.341

8.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

9.  Pharmacy-based needle exchange in New Zealand: a review of services.

Authors:  Janie Sheridan; Charles Henderson; Nicola Greenhill; Andrew Smith
Journal:  Harm Reduct J       Date:  2005-07-12

10.  Syringe access for the prevention of blood borne infections among injection drug users.

Authors:  Sharon Stancliff; Bruce Agins; Josiah D Rich; Scott Burris
Journal:  BMC Public Health       Date:  2003-11-21       Impact factor: 3.295

View more
  14 in total

1.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

2.  Expanding into new territory.

Authors:  Rosemary Killeen
Journal:  Can Pharm J (Ott)       Date:  2012-05

3.  [Not Available].

Authors:  Rosemary Killeen
Journal:  Can Pharm J (Ott)       Date:  2012-05

4.  Pharmacists as vaccinators: An analysis of their experiences and perceptions of their new role.

Authors:  Sandra Gerges; Elizabeth Peter; Susan K Bowles; Shelley Diamond; Lucie Marisa Bucci; Anne Resnick; Anna Taddio
Journal:  Hum Vaccin Immunother       Date:  2017-12-19       Impact factor: 3.452

5.  Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.

Authors:  Yi Yang; Carl Latkin; Rongsheng Luan; Cui Yang
Journal:  Int J Drug Policy       Date:  2015-06-09

6.  Qualitative exploration of the education and skill needs of community pharmacists in Saskatoon concerning substance use disorder.

Authors:  Sarah Fatani; Roy Dobson; Anas El-Aneed
Journal:  Can Pharm J (Ott)       Date:  2019-02-07

7.  PHArmacists' perspective oN the Take hOme naloxone prograM (The PHANTOM Study).

Authors:  Jenny Edwards; Duane Bates; Brett Edwards; Sunita Ghosh; Mark Yarema
Journal:  Can Pharm J (Ott)       Date:  2017-07-07

8.  Australian Community Pharmacy Harm-Minimisation Services: Scope for Service Expansion to Improve Healthcare Access.

Authors:  Sara S McMillan; Hidy Chan; Laetitia H Hattingh
Journal:  Pharmacy (Basel)       Date:  2021-04-26

9.  Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

Authors:  Traci C Green; Emily F Dauria; Jeffrey Bratberg; Corey S Davis; Alexander Y Walley
Journal:  Harm Reduct J       Date:  2015-08-06

10.  Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries.

Authors:  Theodore M Hammett; Son Phan; Julia Gaggin; Patricia Case; Nicholas Zaller; Alexandra Lutnick; Alex H Kral; Ekaterina V Fedorova; Robert Heimer; Will Small; Robin Pollini; Leo Beletsky; Carl Latkin; Don C Des Jarlais
Journal:  BMC Health Serv Res       Date:  2014-06-17       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.